Related Experiment Video
Updated: Jun 17, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Clinical trials: curing a critical deficiency in metabolic medicine
Jerry Vockley1, Catherine M Walsh Vockley
1University of Pittsburgh, Children's Hospital of Pittsburgh of UPMC, One Children's Hospital Drive, 4401 Penn Avenue, Pittsburgh, PA 15224, USA.
Abstract:
The treatment of rare disorders is often driven by experience and expert opinion rather than formal clinical trials because of the significant barriers in place to conducting traditional random, placebo controlled, national studies. Dr. Doug Kerr graphically illustrates these problems in the treatment of inborn errors of mitochondrial oxidative phosphorylation as reviewed elsewhere in this issue. New models and additional funding for studying the ultra rare diseases that are the purview of metabolic medicine are desperately needed to move the field forward in an evidence-based fashion. In this commentary, the challenges associated with conducting clinical trials in ultra-rare disorders are discussed and potential solutions suggested.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Inborn Errors of Metabolism
Pharmacogenomics: Identification of New Drug Targets
Gene Therapy
Overview of Metabolism
Plant Metabolism
Sunlight, the primary source of energy in plants, is first absorbed by the chlorophyll pigments present in their leaves. Plants then use this energy to carry out photosynthesis, where water is oxidized into oxygen and carbon dioxide...

